Delivery Order SPE2DB22D1106-SPE2DB25FDNN1

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,526.08 Firm Fixed Price delivery order is for the supply of 4,564,641,625 units of Spiriva Handihaler 18 mcg capsules in 90-count packages. The contract has an ultimate completion date of May 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop...
This federal contract award, valued at $2,601.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Spiriva Handihaler 18 MCG CAP 30S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract is a Firm Fixed Price Delivery Order with a completion date of December 3, 2024. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,409.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Spiriva Handihaler 18 mcg capsules. The contract is a delivery order with a firm fixed price, and the ultimate completion date is August 6, 2024. This award is not associated with a set-aside program. As a significant supplier of pharmaceutical and medical products to the U.S. government, AmerisourceBergen holds...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,251.54 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Spiriva Handihaler 18 mcg capsules and has a period of performance through June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $4,473.45, is for the delivery of Spiriva Handihaler 18 mcg capsules. This is a firm-fixed-price delivery order with a completion date of May 19, 2023. The contract is not designated with a set-aside requirement, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This is a federal contract award to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,840.92, is for the delivery of SPIRIVA HANDIHALER 18 MCG CAP 30S, a respiratory medication. This is a Firm Fixed Price Delivery Order contract with a period of performance through November 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,620.04 Firm Fixed Price Delivery Order is for the supply of SPIRIVA HANDIHALER 18 MCG CAP 30S, a respiratory medication, with a period of performance through January 16, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $15,727.95 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Spiriva Handihaler 18 mcg capsules, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of November 14, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $14,222.42 Firm Fixed Price Delivery Order is for the supply of Spiriva HandiHaler 18 mcg capsules. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Spiriva Handihaler 18 mcg capsules. The firm-fixed-price delivery order, valued at $2,848.01, has a completion date of September 20, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDNN1
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,571.33, is for the delivery of Spiriva HandiHaler 18 mcg capsules over a two-year period, with a completion date of December 3, 2024.

The contract is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 3/3/25, 12:30 PM